首页> 外文期刊>The journal of immunology >The Extracellular Adherence Protein from Staphylococcus aureus Inhibits the Classical and Lectin Pathways of Complement by Blocking Formation of the C3 Proconvertase
【24h】

The Extracellular Adherence Protein from Staphylococcus aureus Inhibits the Classical and Lectin Pathways of Complement by Blocking Formation of the C3 Proconvertase

机译:金黄色葡萄球菌的细胞外粘附蛋白通过阻止C3前转化酶的形成来抑制补体的经典和凝集素途径。

获取原文
           

摘要

The pathogenic bacterium Staphylococcus aureus actively evades many aspects of human innate immunity by expressing a series of small inhibitory proteins. A number of these proteins inhibit the complement system, which labels bacteria for phagocytosis and generates inflammatory chemoattractants. Although the majority of staphylococcal complement inhibitors act on the alternative pathway to block the amplification loop, only a few proteins act on the initial recognition cascades that constitute the classical pathway (CP) and lectin pathway (LP). We screened a collection of recombinant, secreted staphylococcal proteins to determine whether S. aureus produces other molecules that inhibit the CP and/or LP. Using this approach, we identified the extracellular adherence protein (Eap) as a potent, specific inhibitor of both the CP and LP. We found that Eap blocked CP/LP-dependent activation of C3, but not C4, and that Eap likewise inhibited deposition of C3b on the surface of S. aureus cells. In turn, this significantly diminished the extent of S. aureus opsonophagocytosis and killing by neutrophils. This combination of functional properties suggested that Eap acts specifically at the level of the CP/LP C3 convertase (C4b2a). Indeed, we demonstrated a direct, nanomolar-affinity interaction of Eap with C4b. Eap binding to C4b inhibited binding of both full-length C2 and its C2b fragment, which indicated that Eap disrupts formation of the CP/LP C3 proconvertase (C4b2). As a whole, our results demonstrate that S. aureus inhibits two initiation routes of complement by expression of the Eap protein, and thereby define a novel mechanism of immune evasion. This article is featured in In This Issue , p.[5761][1] [1]: /lookup/volpage/193/5761
机译:致病性细菌金黄色葡萄球菌通过表达一系列小抑制蛋白,主动规避了人类固有免疫力的许多方面。这些蛋白质中的许多抑制补体系统,该系统标记细菌吞噬作用并产生炎性趋化因子。尽管大多数葡萄球菌补体抑制剂在替代途径上发挥作用,以阻断扩增环,但只有少数蛋白质在构成经典途径(CP)和凝集素途径(LP)的初始识别级联反应中起作用。我们筛选了重组的,分泌的葡萄球菌蛋白质的集合,以确定金黄色葡萄球菌是否产生抑制CP和/或LP的其他分子。使用这种方法,我们确定了细胞外粘附蛋白(Eap)是CP和LP的有效,特异性抑制剂。我们发现Eap阻止了C3的CP / LP依赖性激活,但没有阻止C4,并且Eap同样抑制了C3b在金黄色葡萄球菌细胞表面的沉积。反过来,这大大减少了金黄色葡萄球菌吞噬细胞和中性粒细胞杀死的程度。功能特性的这种组合表明,Eap在CP / LP C3转化酶(C4b2a)的​​水平上特异起作用。实际上,我们证明了Eap与C4b的直接,纳摩尔亲和力相互作用。 Eap与C4b的结合抑制了全长C2及其C2b片段的结合,这表明Eap破坏了CP / LP C3前转化酶(C4b2)的形成。总体而言,我们的结果表明,金黄色葡萄球菌通过Eap蛋白的表达抑制两条补体起始途径,从而定义了一种新的免疫逃逸机制。这篇文章在本期专刊中,第[5761] [1]页[1]:/ lookup / volpage / 193/5761

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号